UA98612C2 - Імуногенна композиція, придатна для людини, що включає антиген або антигенний препарат у комбінації з ад'ювантом, який містить qs21 у формі ліпосоми та 3d-mpl - Google Patents

Імуногенна композиція, придатна для людини, що включає антиген або антигенний препарат у комбінації з ад'ювантом, який містить qs21 у формі ліпосоми та 3d-mpl Download PDF

Info

Publication number: UA98612C2
Authority: UA; Ukraine
Prior art keywords: antigen; adjuvant; influenza; vaccine; immunogenic composition
Prior art date: 2005-12-13

Application number

UAA200807167A

Other languages

English (en)

Russian (ru)

Ukrainian (uk)

Inventor

Пьерр Вандпаплиер

Original Assignee

ГлаксоСмитКлайн Байолоджикалз с.а.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-13

Filing date

2006-12-12

Publication date

2012-06-11

2006-12-12 Application filed by ГлаксоСмитКлайн Байолоджикалз с.а. filed Critical ГлаксоСмитКлайн Байолоджикалз с.а.

2012-06-11 Publication of UA98612C2 publication Critical patent/UA98612C2/uk

Links

239000000203 mixture Substances 0.000 title claims abstract description 482
108091007433 antigens Proteins 0.000 title claims abstract description 359
102000036639 antigens Human genes 0.000 title claims abstract description 359
239000000427 antigen Substances 0.000 title claims abstract description 358
239000002671 adjuvant Substances 0.000 title claims abstract description 319
230000002163 immunogen Effects 0.000 title claims abstract description 129
238000002360 preparation method Methods 0.000 title claims abstract description 124
239000002502 liposome Substances 0.000 title claims abstract description 85
230000000890 antigenic effect Effects 0.000 title claims abstract description 79
241000282414 Homo sapiens Species 0.000 title claims abstract description 72
150000007949 saponins Chemical class 0.000 claims abstract description 59
229930182490 saponin Natural products 0.000 claims abstract description 57
239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 51
108090000623 proteins and genes Proteins 0.000 claims description 140
102000004169 proteins and genes Human genes 0.000 claims description 138
241000700605 Viruses Species 0.000 claims description 100
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 50
150000001413 amino acids Chemical class 0.000 claims description 31
229930182558 Sterol Natural products 0.000 claims description 27
150000003432 sterols Chemical class 0.000 claims description 27
235000003702 sterols Nutrition 0.000 claims description 27
235000012000 cholesterol Nutrition 0.000 claims description 25
239000012634 fragment Substances 0.000 claims description 24
239000003814 drug Substances 0.000 claims description 15
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 claims 1
239000002158 endotoxin Substances 0.000 abstract description 45
229920006008 lipopolysaccharide Polymers 0.000 abstract description 45
235000009001 Quillaja saponaria Nutrition 0.000 abstract description 2
241001092142 Molina Species 0.000 abstract 1
241001454523 Quillaja saponaria Species 0.000 abstract 1
229960005486 vaccine Drugs 0.000 description 269
206010022000 influenza Diseases 0.000 description 184
238000002255 vaccination Methods 0.000 description 167
235000018102 proteins Nutrition 0.000 description 137
238000002595 magnetic resonance imaging Methods 0.000 description 133
241000712461 unidentified influenza virus Species 0.000 description 107
210000004027 cell Anatomy 0.000 description 104
210000001744 T-lymphocyte Anatomy 0.000 description 98
102100033772 Complement C4-A Human genes 0.000 description 90
238000009472 formulation Methods 0.000 description 89
238000012360 testing method Methods 0.000 description 77
230000003053 immunization Effects 0.000 description 76
238000002649 immunization Methods 0.000 description 75
238000000034 method Methods 0.000 description 71
241000699670 Mus sp. Species 0.000 description 70
229960003971 influenza vaccine Drugs 0.000 description 62
210000002966 serum Anatomy 0.000 description 58
238000006243 chemical reaction Methods 0.000 description 57
239000000185 hemagglutinin Substances 0.000 description 55
101710154606 Hemagglutinin Proteins 0.000 description 53
101710093908 Outer capsid protein VP4 Proteins 0.000 description 53
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 53
101710176177 Protein A56 Proteins 0.000 description 53
235000017709 saponins Nutrition 0.000 description 53
102000004127 Cytokines Human genes 0.000 description 52
108090000695 Cytokines Proteins 0.000 description 52
150000001720 carbohydrates Chemical class 0.000 description 45
239000008055 phosphate buffer solution Substances 0.000 description 44
230000000694 effects Effects 0.000 description 43
230000004044 response Effects 0.000 description 39
239000000243 solution Substances 0.000 description 39
230000035931 haemagglutination Effects 0.000 description 35
230000028993 immune response Effects 0.000 description 35
239000002245 particle Substances 0.000 description 35
238000004458 analytical method Methods 0.000 description 34
238000004519 manufacturing process Methods 0.000 description 34
238000012770 revaccination Methods 0.000 description 33
108090000765 processed proteins & peptides Proteins 0.000 description 32
238000010790 dilution Methods 0.000 description 30
239000012895 dilution Substances 0.000 description 30
241000282412 Homo Species 0.000 description 28
241000282339 Mustela Species 0.000 description 28
230000005764 inhibitory process Effects 0.000 description 28
238000002347 injection Methods 0.000 description 27
239000007924 injection Substances 0.000 description 27
210000003719 b-lymphocyte Anatomy 0.000 description 26
108020001507 fusion proteins Proteins 0.000 description 26
102000037865 fusion proteins Human genes 0.000 description 26
229920001282 polysaccharide Polymers 0.000 description 26
239000005017 polysaccharide Substances 0.000 description 26
150000004676 glycans Chemical class 0.000 description 25
239000007788 liquid Substances 0.000 description 25
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
230000003308 immunostimulating effect Effects 0.000 description 24
230000000875 corresponding effect Effects 0.000 description 23
229960001438 immunostimulant agent Drugs 0.000 description 23
239000003022 immunostimulating agent Substances 0.000 description 23
206010028980 Neoplasm Diseases 0.000 description 22
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22
208000015181 infectious disease Diseases 0.000 description 22
238000002156 mixing Methods 0.000 description 22
201000010099 disease Diseases 0.000 description 20
238000011156 evaluation Methods 0.000 description 20
102000004196 processed proteins & peptides Human genes 0.000 description 20
230000028996 humoral immune response Effects 0.000 description 19
239000003599 detergent Substances 0.000 description 18
102000014914 Carrier Proteins Human genes 0.000 description 17
108010078791 Carrier Proteins Proteins 0.000 description 17
208000024891 symptom Diseases 0.000 description 17
239000004698 Polyethylene Substances 0.000 description 16
238000002474 experimental method Methods 0.000 description 16
238000011534 incubation Methods 0.000 description 16
GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 16
230000005847 immunogenicity Effects 0.000 description 15
229960000814 tetanus toxoid Drugs 0.000 description 15
230000003612 virological effect Effects 0.000 description 15
239000003708 ampul Substances 0.000 description 14
230000008348 humoral response Effects 0.000 description 14
208000037956 transmissible mink encephalopathy Diseases 0.000 description 14
238000011282 treatment Methods 0.000 description 14
239000008215 water for injection Substances 0.000 description 14
241000287828 Gallus gallus Species 0.000 description 13
241000701806 Human papillomavirus Species 0.000 description 13
210000003743 erythrocyte Anatomy 0.000 description 13
239000008363 phosphate buffer Substances 0.000 description 13
230000000638 stimulation Effects 0.000 description 13
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
239000013504 Triton X-100 Substances 0.000 description 12
229920004890 Triton X-100 Polymers 0.000 description 12
229940079593 drug Drugs 0.000 description 12
238000006386 neutralization reaction Methods 0.000 description 12
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 12
229920000053 polysorbate 80 Polymers 0.000 description 12
210000002845 virion Anatomy 0.000 description 12
238000013459 approach Methods 0.000 description 11
230000036541 health Effects 0.000 description 11
150000002632 lipids Chemical class 0.000 description 11
230000001404 mediated effect Effects 0.000 description 11
108091003079 Bovine Serum Albumin Proteins 0.000 description 10
241001465754 Metazoa Species 0.000 description 10
230000005867 T cell response Effects 0.000 description 10
210000004899 c-terminal region Anatomy 0.000 description 10
229960001231 choline Drugs 0.000 description 10
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 10
230000009260 cross reactivity Effects 0.000 description 10
230000004927 fusion Effects 0.000 description 10
239000011521 glass Substances 0.000 description 10
238000010255 intramuscular injection Methods 0.000 description 10
239000007927 intramuscular injection Substances 0.000 description 10
239000012528 membrane Substances 0.000 description 10
210000004379 membrane Anatomy 0.000 description 10
230000002085 persistent effect Effects 0.000 description 10
230000002265 prevention Effects 0.000 description 10
238000007619 statistical method Methods 0.000 description 10
239000003053 toxin Substances 0.000 description 10
231100000765 toxin Toxicity 0.000 description 10
108700012359 toxins Proteins 0.000 description 10
101710164918 Choline-binding protein Proteins 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
102000005348 Neuraminidase Human genes 0.000 description 9
108010006232 Neuraminidase Proteins 0.000 description 9
238000003556 assay Methods 0.000 description 9
230000008901 benefit Effects 0.000 description 9
238000012217 deletion Methods 0.000 description 9
230000037430 deletion Effects 0.000 description 9
230000001900 immune effect Effects 0.000 description 9
230000008105 immune reaction Effects 0.000 description 9
230000003834 intracellular effect Effects 0.000 description 9
238000010212 intracellular staining Methods 0.000 description 9
239000002609 medium Substances 0.000 description 9
230000003472 neutralizing effect Effects 0.000 description 9
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 9
230000009467 reduction Effects 0.000 description 9
230000009466 transformation Effects 0.000 description 9
108090000288 Glycoproteins Proteins 0.000 description 8
102000003886 Glycoproteins Human genes 0.000 description 8
241000831652 Salinivibrio sharmensis Species 0.000 description 8
230000004913 activation Effects 0.000 description 8
239000000872 buffer Substances 0.000 description 8
201000011510 cancer Diseases 0.000 description 8
238000003776 cleavage reaction Methods 0.000 description 8
235000013601 eggs Nutrition 0.000 description 8
238000011049 filling Methods 0.000 description 8
238000005259 measurement Methods 0.000 description 8
230000008520 organization Effects 0.000 description 8
239000000843 powder Substances 0.000 description 8
210000002307 prostate Anatomy 0.000 description 8
230000007017 scission Effects 0.000 description 8
238000013207 serial dilution Methods 0.000 description 8
239000002904 solvent Substances 0.000 description 8
238000010186 staining Methods 0.000 description 8
229940031626 subunit vaccine Drugs 0.000 description 8
229940125575 vaccine candidate Drugs 0.000 description 8
238000005406 washing Methods 0.000 description 8
241000701022 Cytomegalovirus Species 0.000 description 7
108010001336 Horseradish Peroxidase Proteins 0.000 description 7
208000002193 Pain Diseases 0.000 description 7
229920001213 Polysorbate 20 Polymers 0.000 description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
230000036760 body temperature Effects 0.000 description 7
239000012894 fetal calf serum Substances 0.000 description 7
208000002672 hepatitis B Diseases 0.000 description 7
230000036039 immunity Effects 0.000 description 7
201000004792 malaria Diseases 0.000 description 7
244000052769 pathogen Species 0.000 description 7
230000001717 pathogenic effect Effects 0.000 description 7
210000004180 plasmocyte Anatomy 0.000 description 7
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 7
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 7
229920001184 polypeptide Polymers 0.000 description 7
239000000725 suspension Substances 0.000 description 7
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
208000017667 Chronic Disease Diseases 0.000 description 6
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
241000700721 Hepatitis B virus Species 0.000 description 6
108010052285 Membrane Proteins Proteins 0.000 description 6
108010076504 Protein Sorting Signals Proteins 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
239000002253 acid Substances 0.000 description 6
230000005875 antibody response Effects 0.000 description 6
230000001580 bacterial effect Effects 0.000 description 6
244000309466 calf Species 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 6
230000016396 cytokine production Effects 0.000 description 6
238000000684 flow cytometry Methods 0.000 description 6
208000026278 immune system disease Diseases 0.000 description 6
239000003112 inhibitor Substances 0.000 description 6
230000003993 interaction Effects 0.000 description 6
229920002704 polyhistidine Polymers 0.000 description 6
230000008569 process Effects 0.000 description 6
238000012216 screening Methods 0.000 description 6
210000004989 spleen cell Anatomy 0.000 description 6
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
241000271566 Aves Species 0.000 description 5
206010008342 Cervix carcinoma Diseases 0.000 description 5
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
101710094581 Distal tail protein Proteins 0.000 description 5
235000010469 Glycine max Nutrition 0.000 description 5
102000018697 Membrane Proteins Human genes 0.000 description 5
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 5
235000009421 Myristica fragrans Nutrition 0.000 description 5
206010035664 Pneumonia Diseases 0.000 description 5
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 5
238000010162 Tukey test Methods 0.000 description 5
208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 5
201000010881 cervical cancer Diseases 0.000 description 5
108091016312 choline binding proteins Proteins 0.000 description 5
238000013501 data transformation Methods 0.000 description 5
238000013461 design Methods 0.000 description 5
239000006185 dispersion Substances 0.000 description 5
238000009826 distribution Methods 0.000 description 5
210000002257 embryonic structure Anatomy 0.000 description 5
239000010410 layer Substances 0.000 description 5
-1 lethal toxicity Substances 0.000 description 5
239000001115 mace Substances 0.000 description 5
210000005259 peripheral blood Anatomy 0.000 description 5
239000011886 peripheral blood Substances 0.000 description 5
210000005105 peripheral blood lymphocyte Anatomy 0.000 description 5
239000000047 product Substances 0.000 description 5
238000000746 purification Methods 0.000 description 5
238000010791 quenching Methods 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
230000028327 secretion Effects 0.000 description 5
239000007787 solid Substances 0.000 description 5
238000004793 spatially offset Raman spectroscopy Methods 0.000 description 5
239000000758 substrate Substances 0.000 description 5
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 5
238000004448 titration Methods 0.000 description 5
231100000419 toxicity Toxicity 0.000 description 5
230000001988 toxicity Effects 0.000 description 5
238000000844 transformation Methods 0.000 description 5
229940031418 trivalent vaccine Drugs 0.000 description 5
MYLBTCQBKAKUTJ-UHFFFAOYSA-N 7-methyl-6,8-bis(methylsulfanyl)pyrrolo[1,2-a]pyrazine Chemical compound C1=CN=CC2=C(SC)C(C)=C(SC)N21 MYLBTCQBKAKUTJ-UHFFFAOYSA-N 0.000 description 4
241000894006 Bacteria Species 0.000 description 4
241000700198 Cavia Species 0.000 description 4
241000254173 Coleoptera Species 0.000 description 4
244000068988 Glycine max Species 0.000 description 4
241000371980 Influenza B virus (B/Shanghai/361/2002) Species 0.000 description 4
241000699666 Mus <mouse, genus> Species 0.000 description 4
101100135676 Mus musculus Paxip1 gene Proteins 0.000 description 4
241000283965 Ochotona princeps Species 0.000 description 4
206010033078 Otitis media Diseases 0.000 description 4
229910019142 PO4 Inorganic materials 0.000 description 4
206010037660 Pyrexia Diseases 0.000 description 4
108010090804 Streptavidin Proteins 0.000 description 4
230000002238 attenuated effect Effects 0.000 description 4
238000004113 cell culture Methods 0.000 description 4
239000006285 cell suspension Substances 0.000 description 4
230000008859 change Effects 0.000 description 4
239000011248 coating agent Substances 0.000 description 4
238000000576 coating method Methods 0.000 description 4
229940001442 combination vaccine Drugs 0.000 description 4
230000021615 conjugation Effects 0.000 description 4
238000001914 filtration Methods 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
210000003292 kidney cell Anatomy 0.000 description 4
230000021633 leukocyte mediated immunity Effects 0.000 description 4
210000004072 lung Anatomy 0.000 description 4
210000004698 lymphocyte Anatomy 0.000 description 4
239000000463 material Substances 0.000 description 4
239000007764 o/w emulsion Substances 0.000 description 4
239000010452 phosphate Substances 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
229920006324 polyoxymethylene Polymers 0.000 description 4
229920000136 polysorbate Polymers 0.000 description 4
230000000069 prophylactic effect Effects 0.000 description 4
230000000171 quenching effect Effects 0.000 description 4
238000011160 research Methods 0.000 description 4
102200114279 rs61748120 Human genes 0.000 description 4
230000000405 serological effect Effects 0.000 description 4
210000003491 skin Anatomy 0.000 description 4
DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 4
241000894007 species Species 0.000 description 4
239000007921 spray Substances 0.000 description 4
238000011146 sterile filtration Methods 0.000 description 4
238000003756 stirring Methods 0.000 description 4
239000000126 substance Substances 0.000 description 4
238000002560 therapeutic procedure Methods 0.000 description 4
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 4
239000000277 virosome Substances 0.000 description 4
SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 3
CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical compound N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 description 3
208000030507 AIDS Diseases 0.000 description 3
102100034613 Annexin A2 Human genes 0.000 description 3
108090000668 Annexin A2 Proteins 0.000 description 3
241000282465 Canis Species 0.000 description 3
108020004414 DNA Proteins 0.000 description 3
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
206010060891 General symptom Diseases 0.000 description 3
239000004471 Glycine Substances 0.000 description 3
108060003393 Granulin Proteins 0.000 description 3
101000969989 Homo sapiens Nurim Proteins 0.000 description 3
241000712431 Influenza A virus Species 0.000 description 3
241000124008 Mammalia Species 0.000 description 3
102100021773 Nurim Human genes 0.000 description 3
229930040373 Paraformaldehyde Natural products 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
201000005702 Pertussis Diseases 0.000 description 3
102100035181 Plastin-1 Human genes 0.000 description 3
235000011449 Rosa Nutrition 0.000 description 3
238000011869 Shapiro-Wilk test Methods 0.000 description 3
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
108010003533 Viral Envelope Proteins Proteins 0.000 description 3
238000001793 Wilcoxon signed-rank test Methods 0.000 description 3
230000004520 agglutination Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
229960002685 biotin Drugs 0.000 description 3
235000020958 biotin Nutrition 0.000 description 3
239000011616 biotin Substances 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
229940098773 bovine serum albumin Drugs 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
239000007979 citrate buffer Substances 0.000 description 3
230000035622 drinking Effects 0.000 description 3
239000008187 granular material Substances 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
238000000265 homogenisation Methods 0.000 description 3
238000010166 immunofluorescence Methods 0.000 description 3
238000011221 initial treatment Methods 0.000 description 3
238000007918 intramuscular administration Methods 0.000 description 3
210000001161 mammalian embryo Anatomy 0.000 description 3
210000004779 membrane envelope Anatomy 0.000 description 3
238000012544 monitoring process Methods 0.000 description 3
210000005087 mononuclear cell Anatomy 0.000 description 3
230000035772 mutation Effects 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
229920002866 paraformaldehyde Polymers 0.000 description 3
244000045947 parasite Species 0.000 description 3
108010049148 plastin Proteins 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000000601 reactogenic effect Effects 0.000 description 3
229920006395 saturated elastomer Polymers 0.000 description 3
238000004904 shortening Methods 0.000 description 3
230000004936 stimulating effect Effects 0.000 description 3
230000008961 swelling Effects 0.000 description 3
229960005367 tetanus antitoxin Drugs 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
229940033663 thimerosal Drugs 0.000 description 3
201000008827 tuberculosis Diseases 0.000 description 3
230000009385 viral infection Effects 0.000 description 3
OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
WFZFMHDDZRBTFH-CZEFNJPISA-N 2-[(e)-2-(5-carbamimidoyl-1-benzofuran-2-yl)ethenyl]-1-benzofuran-5-carboximidamide;dihydrochloride Chemical compound Cl.Cl.NC(=N)C1=CC=C2OC(/C=C/C=3OC4=CC=C(C=C4C=3)C(=N)N)=CC2=C1 WFZFMHDDZRBTFH-CZEFNJPISA-N 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N 2-mercaptoethanol Substances OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
241000157282 Aesculus Species 0.000 description 2
101710186708 Agglutinin Proteins 0.000 description 2
241000272525 Anas platyrhynchos Species 0.000 description 2
206010059313 Anogenital warts Diseases 0.000 description 2
101000995861 Arabidopsis thaliana Regulatory protein NPR1 Proteins 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
208000003508 Botulism Diseases 0.000 description 2
101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 description 2
101100425522 Caenorhabditis elegans mys-1 gene Proteins 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
241000543381 Cliftonia monophylla Species 0.000 description 2
208000035473 Communicable disease Diseases 0.000 description 2
208000000907 Condylomata Acuminata Diseases 0.000 description 2
241000699802 Cricetulus griseus Species 0.000 description 2
IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 2
102000002322 Egg Proteins Human genes 0.000 description 2
108010000912 Egg Proteins Proteins 0.000 description 2
241000991587 Enterovirus C Species 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
206010018852 Haematoma Diseases 0.000 description 2
206010019233 Headaches Diseases 0.000 description 2
241000238631 Hexapoda Species 0.000 description 2
101000600885 Homo sapiens Serine/threonine-protein kinase NIM1 Proteins 0.000 description 2
101710146024 Horcolin Proteins 0.000 description 2
241000701024 Human betaherpesvirus 5 Species 0.000 description 2
241000725303 Human immunodeficiency virus Species 0.000 description 2
241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
206010020751 Hypersensitivity Diseases 0.000 description 2
241000713196 Influenza B virus Species 0.000 description 2
102000008070 Interferon-gamma Human genes 0.000 description 2
108010074328 Interferon-gamma Proteins 0.000 description 2
102100034872 Kallikrein-4 Human genes 0.000 description 2
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
101710189395 Lectin Proteins 0.000 description 2
108090001030 Lipoproteins Proteins 0.000 description 2
102000004895 Lipoproteins Human genes 0.000 description 2
101710105759 Major outer membrane porin Proteins 0.000 description 2
101710164702 Major outer membrane protein Proteins 0.000 description 2
101710179758 Mannose-specific lectin Proteins 0.000 description 2
101710150763 Mannose-specific lectin 1 Proteins 0.000 description 2
101710150745 Mannose-specific lectin 2 Proteins 0.000 description 2
101710085938 Matrix protein Proteins 0.000 description 2
108010090054 Membrane Glycoproteins Proteins 0.000 description 2
102000012750 Membrane Glycoproteins Human genes 0.000 description 2
101710127721 Membrane protein Proteins 0.000 description 2
241000282341 Mustela putorius furo Species 0.000 description 2
102000011931 Nucleoproteins Human genes 0.000 description 2
108010061100 Nucleoproteins Proteins 0.000 description 2
241001631646 Papillomaviridae Species 0.000 description 2
101710183389 Pneumolysin Proteins 0.000 description 2
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
239000004365 Protease Substances 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
102000012479 Serine Proteases Human genes 0.000 description 2
108010022999 Serine Proteases Proteins 0.000 description 2
102100037345 Serine/threonine-protein kinase NIM1 Human genes 0.000 description 2
241000700584 Simplexvirus Species 0.000 description 2
101710172711 Structural protein Proteins 0.000 description 2
230000024932 T cell mediated immunity Effects 0.000 description 2
206010043376 Tetanus Diseases 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
208000000260 Warts Diseases 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
230000000240 adjuvant effect Effects 0.000 description 2
230000002411 adverse Effects 0.000 description 2
239000000910 agglutinin Substances 0.000 description 2
230000007815 allergy Effects 0.000 description 2
ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 2
208000025009 anogenital human papillomavirus infection Diseases 0.000 description 2
201000004201 anogenital venereal wart Diseases 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
239000000969 carrier Substances 0.000 description 2
230000003197 catalytic effect Effects 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000011109 contamination Methods 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
239000012228 culture supernatant Substances 0.000 description 2
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000034994 death Effects 0.000 description 2
231100000517 death Toxicity 0.000 description 2
210000004443 dendritic cell Anatomy 0.000 description 2
238000001212 derivatisation Methods 0.000 description 2
210000004207 dermis Anatomy 0.000 description 2
239000013024 dilution buffer Substances 0.000 description 2
206010013023 diphtheria Diseases 0.000 description 2
238000001647 drug administration Methods 0.000 description 2
238000002296 dynamic light scattering Methods 0.000 description 2
210000003162 effector t lymphocyte Anatomy 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
239000003797 essential amino acid Substances 0.000 description 2
235000020776 essential amino acid Nutrition 0.000 description 2
206010016256 fatigue Diseases 0.000 description 2
238000011832 ferret model Methods 0.000 description 2
102000013361 fetuin Human genes 0.000 description 2
108060002885 fetuin Proteins 0.000 description 2
239000012530 fluid Substances 0.000 description 2
230000006870 function Effects 0.000 description 2
229940044627 gamma-interferon Drugs 0.000 description 2
238000002523 gelfiltration Methods 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
231100000869 headache Toxicity 0.000 description 2
108060003552 hemocyanin Proteins 0.000 description 2
102000022382 heparin binding proteins Human genes 0.000 description 2
108091012216 heparin binding proteins Proteins 0.000 description 2
208000006454 hepatitis Diseases 0.000 description 2
231100000283 hepatitis Toxicity 0.000 description 2
235000010181 horse chestnut Nutrition 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
230000000951 immunodiffusion Effects 0.000 description 2
230000001024 immunotherapeutic effect Effects 0.000 description 2
239000007943 implant Substances 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
208000037798 influenza B Diseases 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
239000002054 inoculum Substances 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
108010024383 kallikrein 4 Proteins 0.000 description 2
238000002372 labelling Methods 0.000 description 2
229960001226 live attenuated influenza Drugs 0.000 description 2
230000033001 locomotion Effects 0.000 description 2
239000008176 lyophilized powder Substances 0.000 description 2
201000001441 melanoma Diseases 0.000 description 2
238000001462 microwave scanning near-field microscopy Methods 0.000 description 2
239000000178 monomer Substances 0.000 description 2
229940035032 monophosphoryl lipid a Drugs 0.000 description 2
229940031348 multivalent vaccine Drugs 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
210000001989 nasopharynx Anatomy 0.000 description 2
CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
229920001542 oligosaccharide Polymers 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
210000001672 ovary Anatomy 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
239000008188 pellet Substances 0.000 description 2
108010021711 pertactin Proteins 0.000 description 2
WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
150000003904 phospholipids Chemical class 0.000 description 2
239000011148 porous material Substances 0.000 description 2
229940071643 prefilled syringe Drugs 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
229920002477 rna polymer Polymers 0.000 description 2
230000003248 secreting effect Effects 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
201000010153 skin papilloma Diseases 0.000 description 2
239000000344 soap Substances 0.000 description 2
229940054269 sodium pyruvate Drugs 0.000 description 2
210000000952 spleen Anatomy 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
239000003826 tablet Substances 0.000 description 2
229940031351 tetravalent vaccine Drugs 0.000 description 2
229960004906 thiomersal Drugs 0.000 description 2
238000011247 total mesorectal excision Methods 0.000 description 2
229960001005 tuberculin Drugs 0.000 description 2
241001529453 unidentified herpesvirus Species 0.000 description 2
229910052727 yttrium Inorganic materials 0.000 description 2
CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 2
RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
IJFVSSZAOYLHEE-UHFFFAOYSA-N 2,3-di(dodecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC IJFVSSZAOYLHEE-UHFFFAOYSA-N 0.000 description 1
UEJJHQNACJXSKW-UHFFFAOYSA-N 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)NC1=O UEJJHQNACJXSKW-UHFFFAOYSA-N 0.000 description 1
NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 description 1
WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
MCNQUWLLXZZZAC-UHFFFAOYSA-N 4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-n-piperidin-1-ylpyrazole-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=C(C#N)C(C(=O)NN2CCCCC2)=NN1C1=CC=C(Cl)C=C1Cl MCNQUWLLXZZZAC-UHFFFAOYSA-N 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
240000006108 Allium ampeloprasum Species 0.000 description 1
239000005995 Aluminium silicate Substances 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
241000605281 Anaplasma phagocytophilum Species 0.000 description 1
235000019737 Animal fat Nutrition 0.000 description 1
101710145634 Antigen 1 Proteins 0.000 description 1
101100011518 Arabidopsis thaliana ELP1 gene Proteins 0.000 description 1
101100412417 Arabidopsis thaliana REM5 gene Proteins 0.000 description 1
208000031504 Asymptomatic Infections Diseases 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
101100493813 Bacillus subtilis (strain 168) besA gene Proteins 0.000 description 1
102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
102100021257 Beta-secretase 1 Human genes 0.000 description 1
240000005220 Bischofia javanica Species 0.000 description 1
235000010893 Bischofia javanica Nutrition 0.000 description 1
241000237519 Bivalvia Species 0.000 description 1
206010005003 Bladder cancer Diseases 0.000 description 1
241000566113 Branta sandvicensis Species 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
101100492805 Caenorhabditis elegans atm-1 gene Proteins 0.000 description 1
101100311260 Caenorhabditis elegans sti-1 gene Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
241000282994 Cervidae Species 0.000 description 1
241000283153 Cetacea Species 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
201000006082 Chickenpox Diseases 0.000 description 1
108010049048 Cholera Toxin Proteins 0.000 description 1
102000009016 Cholera Toxin Human genes 0.000 description 1
241000581364 Clinitrachus argentatus Species 0.000 description 1
208000032170 Congenital Abnormalities Diseases 0.000 description 1
206010010356 Congenital anomaly Diseases 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
206010011469 Crying Diseases 0.000 description 1
102100031596 Cytochrome c oxidase assembly factor 4 homolog, mitochondrial Human genes 0.000 description 1
206010011831 Cytomegalovirus infection Diseases 0.000 description 1
ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
101150105088 Dele1 gene Proteins 0.000 description 1
241000725619 Dengue virus Species 0.000 description 1
241001649081 Dina Species 0.000 description 1
108010053187 Diphtheria Toxin Proteins 0.000 description 1
102000016607 Diphtheria Toxin Human genes 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
101000582396 Escherichia phage D108 Repressor c protein Proteins 0.000 description 1
101000582397 Escherichia phage Mu Repressor protein c Proteins 0.000 description 1
241001643597 Evas Species 0.000 description 1
206010016275 Fear Diseases 0.000 description 1
244000025361 Ficus carica Species 0.000 description 1
235000008730 Ficus carica Nutrition 0.000 description 1
241000710831 Flavivirus Species 0.000 description 1
244000182067 Fraxinus ornus Species 0.000 description 1
235000002917 Fraxinus ornus Nutrition 0.000 description 1
RTDFOQVLLJZRIH-JZAVHCKJSA-N Glycoursocholanic acid Chemical compound C([C@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)CC1 RTDFOQVLLJZRIH-JZAVHCKJSA-N 0.000 description 1
239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
102100033969 Guanylyl cyclase-activating protein 1 Human genes 0.000 description 1
208000031886 HIV Infections Diseases 0.000 description 1
208000037357 HIV infectious disease Diseases 0.000 description 1
101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 1
241000711549 Hepacivirus C Species 0.000 description 1
241000724675 Hepatitis E virus Species 0.000 description 1
241000709721 Hepatovirus A Species 0.000 description 1
244000084296 Hernandia moerenhoutiana Species 0.000 description 1
235000010044 Hernandia moerenhoutiana Nutrition 0.000 description 1
102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 description 1
101000993410 Homo sapiens Cytochrome c oxidase assembly factor 4 homolog, mitochondrial Proteins 0.000 description 1
101001068480 Homo sapiens Guanylyl cyclase-activating protein 1 Proteins 0.000 description 1
101001126084 Homo sapiens Piwi-like protein 2 Proteins 0.000 description 1
101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
241000577090 Human DNA virus Species 0.000 description 1
241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
208000002979 Influenza in Birds Diseases 0.000 description 1
206010022004 Influenza like illness Diseases 0.000 description 1
108010029660 Intrinsically Disordered Proteins Proteins 0.000 description 1
241000710842 Japanese encephalitis virus Species 0.000 description 1
101150108662 KAR2 gene Proteins 0.000 description 1
241001397173 Kali <angiosperm> Species 0.000 description 1
241001026509 Kata Species 0.000 description 1
238000012313 Kruskal-Wallis test Methods 0.000 description 1
102000010445 Lactoferrin Human genes 0.000 description 1
241000234435 Lilium Species 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
206010024971 Lower respiratory tract infections Diseases 0.000 description 1
208000019693 Lung disease Diseases 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
108091054438 MHC class II family Proteins 0.000 description 1
241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
101710155913 Major envelope protein Proteins 0.000 description 1
241000211181 Manta Species 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
241000712079 Measles morbillivirus Species 0.000 description 1
208000005647 Mumps Diseases 0.000 description 1
241000711386 Mumps virus Species 0.000 description 1
101100498160 Mus musculus Dach1 gene Proteins 0.000 description 1
101100366988 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) stu-1 gene Proteins 0.000 description 1
244000061176 Nicotiana tabacum Species 0.000 description 1
235000002637 Nicotiana tabacum Nutrition 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
108010077850 Nuclear Localization Signals Proteins 0.000 description 1
241000468053 Obodhiang virus Species 0.000 description 1
241000697033 Ostracion meleagris Species 0.000 description 1
208000005141 Otitis Diseases 0.000 description 1
241001079606 Paches Species 0.000 description 1
208000009608 Papillomavirus Infections Diseases 0.000 description 1
208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
108010046016 Peanut Agglutinin Proteins 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
240000002134 Pentadesma butyracea Species 0.000 description 1
235000000857 Pentadesma butyracea Nutrition 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
208000037581 Persistent Infection Diseases 0.000 description 1
108010081690 Pertussis Toxin Proteins 0.000 description 1
241000283140 Phoca Species 0.000 description 1
101710099976 Photosystem I P700 chlorophyll a apoprotein A1 Proteins 0.000 description 1
244000089486 Phragmites australis subsp australis Species 0.000 description 1
235000014676 Phragmites communis Nutrition 0.000 description 1
102100029365 Piwi-like protein 2 Human genes 0.000 description 1
206010035737 Pneumonia viral Diseases 0.000 description 1
206010035742 Pneumonitis Diseases 0.000 description 1
108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
102100038358 Prostate-specific antigen Human genes 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
241000700159 Rattus Species 0.000 description 1
101100325931 Rattus norvegicus Abo gene Proteins 0.000 description 1
101100453295 Rattus norvegicus Krt12 gene Proteins 0.000 description 1
102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
241000725643 Respiratory syncytial virus Species 0.000 description 1
206010057190 Respiratory tract infections Diseases 0.000 description 1
108050002653 Retinoblastoma protein Proteins 0.000 description 1
241000702670 Rotavirus Species 0.000 description 1
241000159610 Roya <green alga> Species 0.000 description 1
101000999689 Saimiriine herpesvirus 2 (strain 11) Transcriptional regulator ICP22 homolog Proteins 0.000 description 1
241000694414 Sapindus saponaria Species 0.000 description 1
101100271221 Schizosaccharomyces pombe (strain 972 / ATCC 24843) abo1 gene Proteins 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
108010079723 Shiga Toxin Proteins 0.000 description 1
244000258044 Solanum gilo Species 0.000 description 1
235000018650 Solanum gilo Nutrition 0.000 description 1
101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 description 1
241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
241001415849 Strigiformes Species 0.000 description 1
238000003639 Student–Newman–Keuls (SNK) method Methods 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
101800001271 Surface protein Proteins 0.000 description 1
108010002687 Survivin Proteins 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
241000725681 Swine influenza virus Species 0.000 description 1
230000006044 T cell activation Effects 0.000 description 1
108010055044 Tetanus Toxin Proteins 0.000 description 1
241000710771 Tick-borne encephalitis virus Species 0.000 description 1
102000057032 Tissue Kallikreins Human genes 0.000 description 1
108700022175 Tissue Kallikreins Proteins 0.000 description 1
241001648319 Toronia toru Species 0.000 description 1
101710134694 Transcriptional regulator ICP22 homolog Proteins 0.000 description 1
102000010912 Transferrin-Binding Proteins Human genes 0.000 description 1
108010062476 Transferrin-Binding Proteins Proteins 0.000 description 1
101150000446 Tsku gene Proteins 0.000 description 1
206010064390 Tumour invasion Diseases 0.000 description 1
102000003425 Tyrosinase Human genes 0.000 description 1
108060008724 Tyrosinase Proteins 0.000 description 1
HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
206010046306 Upper respiratory tract infection Diseases 0.000 description 1
108010046334 Urease Proteins 0.000 description 1
208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
208000002495 Uterine Neoplasms Diseases 0.000 description 1
206010046980 Varicella Diseases 0.000 description 1
101710123661 Venom allergen 5 Proteins 0.000 description 1
241000607598 Vibrio Species 0.000 description 1
206010047400 Vibrio infections Diseases 0.000 description 1
MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
101100107923 Vitis labrusca AMAT gene Proteins 0.000 description 1
241000710772 Yellow fever virus Species 0.000 description 1
101710151579 Zinc metalloproteinase Proteins 0.000 description 1
GYMWQLRSSDFGEQ-ADRAWKNSSA-N [(3e,8r,9s,10r,13s,14s,17r)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate;(8r,9s,13s,14s,17r)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.O/N=C/1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(OC(C)=O)C#C)[C@@H]4[C@@H]3CCC2=C\1 GYMWQLRSSDFGEQ-ADRAWKNSSA-N 0.000 description 1
210000000683 abdominal cavity Anatomy 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000033289 adaptive immune response Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
108060000200 adenylate cyclase Proteins 0.000 description 1
102000030621 adenylate cyclase Human genes 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
239000013566 allergen Substances 0.000 description 1
229940037003 alum Drugs 0.000 description 1
235000012211 aluminium silicate Nutrition 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
230000027645 antigenic variation Effects 0.000 description 1
239000006286 aqueous extract Substances 0.000 description 1
238000013473 artificial intelligence Methods 0.000 description 1
206010064097 avian influenza Diseases 0.000 description 1
238000010418 babysitting Methods 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
LVKZSFMYNWRPJX-UHFFFAOYSA-N benzenearsonic acid Natural products O[As](O)(=O)C1=CC=CC=C1 LVKZSFMYNWRPJX-UHFFFAOYSA-N 0.000 description 1
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
230000002146 bilateral effect Effects 0.000 description 1
239000003012 bilayer membrane Substances 0.000 description 1
239000003833 bile salt Substances 0.000 description 1
229940093761 bile salts Drugs 0.000 description 1
230000007698 birth defect Effects 0.000 description 1
229940031416 bivalent vaccine Drugs 0.000 description 1
238000010241 blood sampling Methods 0.000 description 1
238000009529 body temperature measurement Methods 0.000 description 1
210000004271 bone marrow stromal cell Anatomy 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
244000309464 bull Species 0.000 description 1
238000009933 burial Methods 0.000 description 1
230000009400 cancer invasion Effects 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
239000012560 cell impurity Substances 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
208000019065 cervical carcinoma Diseases 0.000 description 1
210000003679 cervix uteri Anatomy 0.000 description 1
235000020639 clam Nutrition 0.000 description 1
JBDHZKLJNAIJNC-LLVKDONJSA-N clodinafop-propargyl Chemical compound C1=CC(O[C@H](C)C(=O)OCC#C)=CC=C1OC1=NC=C(Cl)C=C1F JBDHZKLJNAIJNC-LLVKDONJSA-N 0.000 description 1
210000001728 clone cell Anatomy 0.000 description 1
231100001102 clostridial toxin Toxicity 0.000 description 1
238000001246 colloidal dispersion Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
238000006482 condensation reaction Methods 0.000 description 1
238000010924 continuous production Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
238000012937 correction Methods 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
210000000852 deltoid muscle Anatomy 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
210000004268 dentin Anatomy 0.000 description 1
229960003964 deoxycholic acid Drugs 0.000 description 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
230000030609 dephosphorylation Effects 0.000 description 1
238000006209 dephosphorylation reaction Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000007865 diluting Methods 0.000 description 1
229960003983 diphtheria toxoid Drugs 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
229940043264 dodecyl sulfate Drugs 0.000 description 1
235000001159 dosh Nutrition 0.000 description 1
244000245171 dosh Species 0.000 description 1
229940000406 drug candidate Drugs 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
239000000428 dust Substances 0.000 description 1
208000001848 dysentery Diseases 0.000 description 1
208000019258 ear infection Diseases 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
210000002969 egg yolk Anatomy 0.000 description 1
235000013345 egg yolk Nutrition 0.000 description 1
MGLDCXPLYOWQRP-UHFFFAOYSA-N eicosa-5,8,11,14-tetraynoic acid Chemical compound CCCCCC#CCC#CCC#CCC#CCCCC(O)=O MGLDCXPLYOWQRP-UHFFFAOYSA-N 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
238000004993 emission spectroscopy Methods 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000000369 enteropathogenic effect Effects 0.000 description 1
231100000249 enterotoxic Toxicity 0.000 description 1
230000002242 enterotoxic effect Effects 0.000 description 1
244000309457 enveloped RNA virus Species 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
229960002061 ergocalciferol Drugs 0.000 description 1
DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000005284 excitation Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000003777 experimental drug Substances 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
210000003414 extremity Anatomy 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000013020 final formulation Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
150000002270 gangliosides Chemical class 0.000 description 1
239000007789 gas Substances 0.000 description 1
229960002442 glucosamine Drugs 0.000 description 1
XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 description 1
229940035638 gonadotropin-releasing hormone Drugs 0.000 description 1
230000012010 growth Effects 0.000 description 1
210000003677 hemocyte Anatomy 0.000 description 1
229940000351 hemocyte Drugs 0.000 description 1
108010037896 heparin-binding hemagglutinin Proteins 0.000 description 1
244000144980 herd Species 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
231100000086 high toxicity Toxicity 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
208000021145 human papilloma virus infection Diseases 0.000 description 1
230000004727 humoral immunity Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
238000003125 immunofluorescent labeling Methods 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
238000009169 immunotherapy Methods 0.000 description 1
229940031551 inactivated vaccine Drugs 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
201000006747 infectious mononucleosis Diseases 0.000 description 1
208000037797 influenza A Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000002262 irrigation Effects 0.000 description 1
238000003973 irrigation Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
239000008274 jelly Substances 0.000 description 1
238000005304 joining Methods 0.000 description 1
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
244000145841 kine Species 0.000 description 1
238000002356 laser light scattering Methods 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
231100000636 lethal dose Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
239000003077 lignite Substances 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
230000029226 lipidation Effects 0.000 description 1
239000006194 liquid suspension Substances 0.000 description 1
244000144972 livestock Species 0.000 description 1
150000004668 long chain fatty acids Chemical class 0.000 description 1
208000030500 lower respiratory tract disease Diseases 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
201000003866 lung sarcoma Diseases 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
STEPQTYSZVCJPV-UHFFFAOYSA-N metazachlor Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)CN1N=CC=C1 STEPQTYSZVCJPV-UHFFFAOYSA-N 0.000 description 1
NFGXHKASABOEEW-LDRANXPESA-N methoprene Chemical compound COC(C)(C)CCCC(C)C\C=C\C(\C)=C\C(=O)OC(C)C NFGXHKASABOEEW-LDRANXPESA-N 0.000 description 1
239000011325 microbead Substances 0.000 description 1
238000002941 microtiter virus yield reduction assay Methods 0.000 description 1
239000011707 mineral Substances 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
208000010805 mumps infectious disease Diseases 0.000 description 1
235000000010 nanu Nutrition 0.000 description 1
244000082862 nanu Species 0.000 description 1
210000002850 nasal mucosa Anatomy 0.000 description 1
239000007922 nasal spray Substances 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
229910052754 neon Inorganic materials 0.000 description 1
GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
101150115538 nero gene Proteins 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
210000002445 nipple Anatomy 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
238000010606 normalization Methods 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
150000003833 nucleoside derivatives Chemical class 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
235000014571 nuts Nutrition 0.000 description 1
229920002113 octoxynol Polymers 0.000 description 1
150000002482 oligosaccharides Chemical class 0.000 description 1
231100000590 oncogenic Toxicity 0.000 description 1
230000002246 oncogenic effect Effects 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
238000001543 one-way ANOVA Methods 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
238000010979 pH adjustment Methods 0.000 description 1
230000003071 parasitic effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
230000002688 persistence Effects 0.000 description 1
210000001539 phagocyte Anatomy 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
229940031999 pneumococcal conjugate vaccine Drugs 0.000 description 1
229940124733 pneumococcal vaccine Drugs 0.000 description 1
229960001973 pneumococcal vaccines Drugs 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
229960000380 propiolactone Drugs 0.000 description 1
208000023958 prostate neoplasm Diseases 0.000 description 1
235000004252 protein component Nutrition 0.000 description 1
238000001273 protein sequence alignment Methods 0.000 description 1
230000012743 protein tagging Effects 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
239000002510 pyrogen Substances 0.000 description 1
238000010814 radioimmunoprecipitation assay Methods 0.000 description 1
229910052761 rare earth metal Inorganic materials 0.000 description 1
239000002994 raw material Substances 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
230000006798 recombination Effects 0.000 description 1
239000012925 reference material Substances 0.000 description 1
238000000611 regression analysis Methods 0.000 description 1
210000003289 regulatory T cell Anatomy 0.000 description 1
230000009711 regulatory function Effects 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
239000011435 rock Substances 0.000 description 1
102200158114 rs796052729 Human genes 0.000 description 1
201000005404 rubella Diseases 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000009738 saturating Methods 0.000 description 1
230000001932 seasonal effect Effects 0.000 description 1
239000013049 sediment Substances 0.000 description 1
229920006012 semi-aromatic polyamide Polymers 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000002356 single layer Substances 0.000 description 1
229950005143 sitosterol Drugs 0.000 description 1
238000005549 size reduction Methods 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
230000003381 solubilizing effect Effects 0.000 description 1
210000003046 sporozoite Anatomy 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
239000008174 sterile solution Substances 0.000 description 1
229940032091 stigmasterol Drugs 0.000 description 1
HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
235000016831 stigmasterol Nutrition 0.000 description 1
BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
210000000434 stratum corneum Anatomy 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
AWDRATDZQPNJFN-VAYUFCLWSA-N taurodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 AWDRATDZQPNJFN-VAYUFCLWSA-N 0.000 description 1
229940118376 tetanus toxin Drugs 0.000 description 1
229940021747 therapeutic vaccine Drugs 0.000 description 1
238000007669 thermal treatment Methods 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
210000002303 tibia Anatomy 0.000 description 1
230000003867 tiredness Effects 0.000 description 1
208000016255 tiredness Diseases 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
230000002103 transcriptional effect Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 1
229960000172 trivalent influenza vaccine Drugs 0.000 description 1
230000001810 trypsinlike Effects 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
239000002691 unilamellar liposome Substances 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
201000005112 urinary bladder cancer Diseases 0.000 description 1
206010046766 uterine cancer Diseases 0.000 description 1
239000012646 vaccine adjuvant Substances 0.000 description 1
229940124931 vaccine adjuvant Drugs 0.000 description 1
230000002477 vacuolizing effect Effects 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
244000052613 viral pathogen Species 0.000 description 1
208000009421 viral pneumonia Diseases 0.000 description 1
230000001018 virulence Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
235000001892 vitamin D2 Nutrition 0.000 description 1
239000011653 vitamin D2 Substances 0.000 description 1
229940126581 whole-virion vaccine Drugs 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1
229940051021 yellow-fever virus Drugs 0.000 description 1
150000003772 α-tocopherols Chemical class 0.000 description 1

Classifications

- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

UAA200807167A 2005-12-13 2006-12-12 Імуногенна композиція, придатна для людини, що включає антиген або антигенний препарат у комбінації з ад'ювантом, який містить qs21 у формі ліпосоми та 3d-mpl UA98612C2 (uk)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0525321.6A GB0525321D0 (en)	2005-12-13	2005-12-13	Novel compositions

Publications (1)

Publication Number	Publication Date
UA98612C2 true UA98612C2 (uk)	2012-06-11

Family

ID=35736013

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA200807167A UA98612C2 (uk)	2005-12-13	2006-12-12	Імуногенна композиція, придатна для людини, що включає антиген або антигенний препарат у комбінації з ад'ювантом, який містить qs21 у формі ліпосоми та 3d-mpl

Country Status (5)

Country	Link
CN (1)	CN101330924A (es)
AR (1)	AR108718A2 (es)
GB (1)	GB0525321D0 (es)
UA (1)	UA98612C2 (es)
ZA (1)	ZA200805025B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101690810B (zh) *	2009-10-21	2011-08-17	辽宁益康生物股份有限公司	一种鸡新城疫、传染性支气管炎、减蛋综合征、禽流感四联灭活疫苗佐剂及其制备方法
US20140072622A1 (en) *	2011-05-17	2014-03-13	Glaxosmithkline Biologicals S.A.	Vaccine against streptococcus pneumoniae
GB201213364D0 (en) *	2012-07-27	2012-09-12	Glaxosmithkline Biolog Sa	Purification process
CN104884081A (zh) *	2012-12-05	2015-09-02	葛兰素史密丝克莱恩生物有限公司	免疫原性组合物
TW201601750A (zh) *	2013-10-03	2016-01-16	Nitto Denko Corp	注射疫苗組合物
CN108853493A (zh) *	2018-07-26	2018-11-23	中国人民解放军陆军军医大学	麦冬皂苷d及其纳米乳在制备疫苗佐剂中的应用

2005
- 2005-12-13 GB GBGB0525321.6A patent/GB0525321D0/en not_active Ceased
2006
- 2006-12-12 UA UAA200807167A patent/UA98612C2/uk unknown
- 2006-12-12 CN CNA2006800471395A patent/CN101330924A/zh active Pending
2008
- 2008-06-09 ZA ZA200805025A patent/ZA200805025B/xx unknown
2017
- 2017-06-13 AR ARP170101607A patent/AR108718A2/es unknown

Also Published As

Publication number	Publication date
AR108718A2 (es)	2018-09-19
CN101330924A (zh)	2008-12-24
GB0525321D0 (en)	2006-01-18
ZA200805025B (en)	2009-10-28

Publication	Publication Date	Title
KR101363879B1 (ko)	2014-02-21	사포닌 애쥬번트를 포함하는 백신 조성물
KR101916787B1 (ko)	2019-01-24	Ｃｄ4 ｔ－세포 및/또는 개선된 ｂ－메모리 세포 반응을 유도하는 인플루엔자 바이러스 및 수중유 에멀젼 애주번트의 용도
EA015817B1 (ru)	2011-12-30	Иммуногенная композиция, содержащая адъювант в виде эмульсии "масло в воде"
KR20100033969A (ko)	2010-03-31	세포 주에서 생산된 인플루엔자 바이러스로부터 유래한 헤마글루티닌을 포함하는 바이로솜, 그의 조성물, 제조 방법, 용도
US12397050B2 (en)	2025-08-26	Universal mammalian influenza vaccine
JP5918870B2 (ja)	2016-05-18	インフルエンザに対する改善されたワクチン接種
UA98612C2 (uk)	2012-06-11	Імуногенна композиція, придатна для людини, що включає антиген або антигенний препарат у комбінації з ад'ювантом, який містить qs21 у формі ліпосоми та 3d-mpl
JP5105524B2 (ja)	2012-12-26	多価鳥インフルエンザウイルス
KR20090064412A (ko)	2009-06-18	면역 반응을 유발 또는 유도하는 방법
KR20120131725A (ko)	2012-12-05	고병원성 조류인플루엔자 ａｈ５ｎ１ 바이러스 유사입자 및 이를 이용한 가금용 백신
CA3192260A1 (en)	2022-02-24	Compositions of sars-cov-2 vaccines based on the receptor binding domain, expressed as a dimer, and the outer membrane vesicle of meningococcal group b bacteria
Schulte	2024	Peptide amphiphile micelles as a universal influenza vaccine delivery vehicle
AU2012247029B2 (en)	2017-02-02	Multivalent Avian Influenza vaccines
BRPI0609519A2 (pt)	2011-10-18	composição, uso de uma composição, método de vacinação, uso de um antìgeno, e, método para a preparação de uma composição imunogênica